All News Indivior PLC Nasdaq

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 14/06/2024 BST			5-day change	1st Jan Change
16.53 ^USD	+1.47%		+1.10%	+8.25%

06-10	Indivior PLC Announces Dosing of First Subject with Indv-2000 in A Phase 2 Study Assessing the Safety and Efficacy of Indv-2000 in Individuals with Opioid Use Disorder	CI
05-23	Indivior Confirms FY24 Outlook	MT

Indivior PLC Announces Dosing of First Subject with Indv-2000 in A Phase 2 Study Assessing the Safety and Efficacy of Indv-2000 in Individuals with Opioid Use Disorder	06-10	CI
Indivior : Financial Document	06-05	PU
Indivior Confirms FY24 Outlook	05-23	MT
Transcript : Indivior PLC - Shareholder/Analyst Call	05-23
Indivior : Special Resolution Passed at the 2024 General Meeting Held on May 23, 2024	05-23	PU
Indivior reconfirms 2024 outlook amid NY-listing decision	05-23	AN
Indivior plc Reaffirms Revenue Guidance for the Year 2024	05-23	CI
Indivior to Host Analyst Teach-in Event in New York City; Reconfirms Full Year 2024 Guidance	05-23	PR
The latest transactions by star managers	05-21
Indivior PLC Announces Board Committee Changes	05-10	CI
Indivior : Notice of 2024 General Meeting	05-03	PU
Deutsche Bank Kicks Off Indivior Coverage at Buy	05-03	MT
Jefferies cuts AJ Bell; Deutsche likes ConvaTec	05-03	AN
Transcript : Indivior PLC, Q1 2024 Earnings Call, Apr 25, 2024	04-25
London-listed Indivior Confirms Plan for Primary Listing in US	04-25	MT
Indivior Seeks Shareholder Nod for Listing in the United States	04-25	CI
UK-listed drugmaker Indivior seeks shareholder nod for US listing	04-25	RE
Indivior shares down despite profit boost on planned shift to New York	04-25	AN
Indivior Reports Higher Q1 Net Income, Net Revenue	04-25	MT
Tranche Update on Indivior PLC's Equity Buyback Plan announced on November 17, 2023.	04-25	CI

No results for this search